Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Activation (1)
- Biological markers (1)
- Body fluids (1)
- Carcinogenesis (1)
- Case-control studies (1)
-
- Chrna5-chrna3-chrnb4 (1)
- Cyp2a6 (1)
- Cyp2b6 (1)
- Cytochrome p-450 cyp2b6 (1)
- Exosomes (1)
- Genes (1)
- Genetic variation (1)
- Genotype (1)
- Homo sapiens (1)
- Logistic models (1)
- Lung (1)
- Lung cancer risk (1)
- Lung neoplasms (1)
- Metabolic (1)
- Metabolism (1)
- Micrornas (1)
- Mir205 (1)
- Mir21 (1)
- Mir4454 (1)
- Neoplasms (1)
- Nicotiana tabacum (1)
- Nicotine (1)
- Nitrosamines (1)
- Odds ratio (1)
- Pilot projects (1)
Articles 1 - 2 of 2
Full-Text Articles in Anatomy
Microrna Molecular Profiling From Matched Tumor And Bio-Fluids In Bladder Cancer, David A. Armstrong, Benjamin B. Green, John D. Seigne, Alan R. Schned, Carmen Marsit
Microrna Molecular Profiling From Matched Tumor And Bio-Fluids In Bladder Cancer, David A. Armstrong, Benjamin B. Green, John D. Seigne, Alan R. Schned, Carmen Marsit
Dartmouth Scholarship
MicroRNAs have been identified as potential cancer biomarkers due to their presence and stability in many body fluids including urine and plasma, but the relationship of the pattern of expression of these messengers across various biological media has not been addressed and could provide important information in order to translate these biomarkers for epidemiologic or clinical use. We analyzed microRNA of matched FFPE-tumor tissue, plasma, urine exosomes (n = 16) and WBCs (n = 11) from patients with bladder cancer, using Nanostring miRNA assays and droplet digital PCR for validation. Pearson correlations were used to compare expression between …
Pilot Study Of Cyp2b6 Genetic Variation To Explore The Contribution Of Nitrosamine Activation To Lung Carcinogenesis, Catherine Wassenaar, Qiong Dong, Christopher Amos, Margaret Spitz, Rachel F. Tyndale
Pilot Study Of Cyp2b6 Genetic Variation To Explore The Contribution Of Nitrosamine Activation To Lung Carcinogenesis, Catherine Wassenaar, Qiong Dong, Christopher Amos, Margaret Spitz, Rachel F. Tyndale
Dartmouth Scholarship
We explored the contribution of nitrosamine metabolism to lung cancer in a pilot investigation of genetic variation in CYP2B6, a high-affinity enzymatic activator of tobacco-specific nitrosamines with a negligible role in nicotine metabolism. Previously we found that variation in CYP2A6 and CHRNA5-CHRNA3-CHRNB4 combined to increase lung cancer risk in a case-control study in European American ever-smokers (n = 860). However, these genes are involved in the pharmacology of both nicotine, through which they alter smoking behaviours, and carcinogenic nitrosamines. Herein, we separated participants by CYP2B6 genotype into a high- vs. low-risk group (*1/*1 + *1/*6 vs. *6/*6). Odds ratios estimated …